RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End Use, By Region, And Segment Forecasts, 2025

The global RNAi technology market size was estimated at USD 2.94 billion in 2024 and is projected to reach USD 9.52 billion by 2033, growing at a CAGR of 14.25% from 2025 to 2033. This market growth is attributed to the increasing prevalence of autoimmune diseases, rare disorders, and cancer across the globe.

Expansion of RNAi-Based Therapeutics

The RNAi technology market is growing rapidly due to strong clinical validation and multiple FDA/EMA approvals, including ONPATTRO, GIVLAARI, OXLUMO, and AMVUTTRA. These approvals have proven that RNAi can be developed into safe and effective therapeutics, boosting confidence among biopharma companies and accelerating investment in RNAi platforms. Its ability to precisely silence disease-causing genes makes RNAi a transformative option for rare genetic and liver-targeted disorders. As approved RNAi therapies show strong clinical and commercial performance, demand for RNAi tools, reagents, and delivery technologies continues to rise.

The growth of the market is being further accelerated by significant pharmaceutical interest. Through partnerships, acquisitions, and internal research and development, businesses such as Alnylam, Arrowhead, Dicerna (Novo Nordisk), AstraZeneca, and Takeda are growing their RNAi pipelines. Through these initiatives, RNAi applications are expanding into the fields of oncology, infectious diseases, and cardiometabolic disorders. Significant investments, enduring collaborations, and specialized RNAi research facilities are propelling clinical activity, product launches, and ongoing innovation. The need for RNAi platforms in drug discovery and clinical development keeps growing as the therapeutic pipeline broadens and industry investment increases.

Advancements in Delivery Technologies

Advances in RNAi delivery systems have become a key growth driver for the RNAi technology industry. Earlier issues, such as poor uptake, rapid degradation, and off-target effects, have been largely addressed through innovations in LNPs, GalNAc-siRNA conjugates, polymer carriers, and viral vectors. These next-generation platforms enhance stability, biodistribution, and tissue-specific targeting, particularly in the liver, a major site for genetic and metabolic disorders. As delivery becomes more efficient and clinically viable, demand for RNAi reagents, delivery kits, and development solutions continues to increase.

In addition, RNAi is expanding beyond liver targets owing to advanced delivery technologies. New strategies, such as targeted nanoparticles, peptide-based carriers, and engineered exosomes, are creating opportunities for applications in infectious diseases, cancer, and the central nervous system. To improve their pipelines and lower development risk, biopharma companies are making significant investments in these delivery innovations.

Global RNAi Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global RNAi technology market report on the basis of product & service, application, end use, and region:

Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
Products
- miRNA
- siRNA
- Others
Service
Application Outlook (Revenue, USD Million, 2021 - 2033)
Drug Discovery & Development
- Neurology
- Oncology
- Infectious Diseases
- Metabolic Diseases
- Others
Functional Genomics
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs & CMOs
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68040-295-6

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product & Service
- 1.2.2. Application
- 1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Expansion of RNAi-based therapeutics
  - 3.2.1.2. Advancements in delivery technologies
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Lack of skilled professionals and research support in developing countries
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

4.1. Product & Service Segment Dashboard
4.2. Global RNAi Technology Market Product & Service Movement Analysis
4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
- 4.4.1. Global Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. miRNA
  - 4.4.2.1. Global miRNA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. siRNA
  - 4.4.3.1. Global siRNA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Services
- 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. RNAi Technology Market: Application Business Analysis

5.1. Application Segment Dashboard
5.2. Global RNAi Technology Market Application, Movement Analysis
5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Drug Discovery & Development
- 5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.2. Neurology
  - 5.4.2.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.3. Oncology
  - 5.4.3.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.4. Infectious Diseases
  - 5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.5. Metabolic Diseases
  - 5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.6. Others
  - 5.4.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Functional Genomics
- 5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
- 5.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. RNAi Technology Market: End Use Business Analysis

6.1. End Use Segment Dashboard
6.2. Global RNAi Technology Market End Use Movement Analysis
6.3. Global RNAi Technology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Academic & Research Institutes
- 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. CROs & CMOs
- 6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, & End Use

7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
- 7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Europe
- 7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Regulatory Framework
  - 7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Regulatory Framework
  - 7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Australia
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Regulatory Framework
  - 7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Regulatory Framework
  - 7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. South Korea
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Regulatory Framework
  - 7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
- 7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Middle East & Africa
- 7.7.1. Middle East & Africa RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Regulatory Framework
  - 7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Regulatory Framework
  - 7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. Regulatory Framework
  - 7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Regulatory Framework
  - 7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Participant's Overview
- 8.4.1. Thermo Fisher Scientific, Inc.
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Merck KGaA
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Creative Biolabs
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. GenScript
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Revvity
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. Promega Corporation
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. OriGene Technologies, Inc.
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. Altogen Biosystems
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. Danaher
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Bioneer Corporation
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

Product Code: GVR-4-68040-295-6

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 4 Global RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 5 Global RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 6 Global RNAi technology market, by region, 2021 - 2033 (USD Million)
Table 7 North America RNAi technology market, by country, 2021 - 2033 (USD Million)
Table 8 North America RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 9 North America RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 10 North America RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 11 U.S. RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 12 U.S. RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 13 U.S. RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 14 Canada RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 15 Canada RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 16 Canada RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 17 Mexico RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 18 Mexico RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 19 Mexico RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 20 Europe RNAi technology market, by country, 2021 - 2033 (USD Million)
Table 21 Europe RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 22 Europe RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 23 Europe RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 24 UK RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 25 UK RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 26 UK RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 27 Germany RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 28 Germany RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 29 Germany RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 30 France RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 31 France RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 32 France RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 33 Italy RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 34 Italy RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 35 Italy RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 36 Spain RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 37 Spain RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 38 Spain RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 39 Denmark RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 40 Denmark RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 41 Denmark RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 42 Sweden RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 43 Sweden RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 44 Sweden RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 45 Norway RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 46 Norway RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 47 Norway RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 48 Asia Pacific RNAi technology market, by country, 2021 - 2033 (USD Million)
Table 49 Asia Pacific RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 50 Asia Pacific RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 51 Asia Pacific RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 52 Japan RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 53 Japan RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 54 Japan RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 55 China RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 56 China RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 57 China RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 58 India RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 59 India RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 60 India RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 61 Australia RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 62 Australia RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 63 Australia RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 64 Thailand RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 65 Thailand RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 66 Thailand RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 67 South Korea RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 68 South Korea RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 69 South Korea RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 70 Latin America RNAi technology market, by country, 2021 - 2033 (USD Million)
Table 71 Latin America RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 72 Latin America RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 73 Latin America RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 74 Brazil RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 75 Brazil RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 76 Brazil RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 77 Argentina RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 78 Argentina RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 79 Argentina RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 80 Middle East & Africa RNAi technology market, by country, 2021 - 2033 (USD Million)
Table 81 Middle East & Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 82 Middle East & Africa RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 83 Middle East & Africa RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 84 South Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 85 South Africa RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 86 South Africa RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 89 Saudi Arabia RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 90 UAE RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 91 UAE RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 92 UAE RNAi technology market, by end use, 2021 - 2033 (USD Million)
Table 93 Kuwait RNAi technology market, by product & service, 2021 - 2033 (USD Million)
Table 94 Kuwait RNAi technology market, by application, 2021 - 2033 (USD Million)
Table 95 Kuwait RNAi technology market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 RNAi technology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 RNAi technology market driver analysis
Fig. 12 RNAi technology market restraint analysis
Fig. 13 RNAi technology market: Porter's analysis
Fig. 14 RNAi technology market: PESTEL analysis
Fig. 15 RNAi technology market: Product & Service outlook and key takeaways
Fig. 16 RNAi technology market: Product & Service market share analysis
Fig. 17 Global RNAi technology by products market, 2021 - 2033 (USD Million)
Fig. 18 Global RNAi technology by miRNA market, 2021 - 2033 (USD Million)
Fig. 19 Global RNAi technology by siRNA market, 2021 - 2033 (USD Million)
Fig. 20 Global RNAi technology by others market, 2021 - 2033 (USD Million)
Fig. 21 Global RNAi technology by service market, 2021 - 2033 (USD Million)
Fig. 22 RNAi technology market: Application outlook and key takeaways
Fig. 23 RNAi technology market: Application market share analysis
Fig. 24 Global RNAi technology by drug discovery & development market, 2021 - 2033 (USD Million)
Fig. 25 Global RNAi technology by neurology market, 2021 - 2033 (USD Million)
Fig. 26 Global RNAi technology by oncology market, 2021 - 2033 (USD Million)
Fig. 27 Global RNAi technology by infectious diseases market, 2021 - 2033 (USD Million)
Fig. 28 Global RNAi technology by metabolic diseases market, 2021 - 2033 (USD Million)
Fig. 29 Global RNAi technology by others market, 2021 - 2033 (USD Million)
Fig. 30 Global RNAi technology by functional genomics market, 2021 - 2033 (USD Million)
Fig. 31 Global RNAi technology others market, 2021 - 2033 (USD Million)
Fig. 32 RNAi technology market: End Use outlook and key takeaways
Fig. 33 RNAi technology market: End Use market share analysis
Fig. 34 Global RNAi technology by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Fig. 35 Global RNAi technology by academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 36 Global RNAi technology by CROs & CMOs market, 2021 - 2033 (USD Million)
Fig. 37 Regional marketplace: Key takeaways
Fig. 38 North America RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 39 U.S. RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 40 Canada RNAi technology market, 2021 - 2033 (USD Million)
Fig. 41 Mexico RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 42 Europe RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 43 UK RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 44 Germany RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 45 France RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 Italy RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 Spain RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Denmark RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 49 Sweden RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 50 Norway RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 51 Asia Pacific RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 52 Japan RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 China RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 54 India RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 55 Australia RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 56 Thailand RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 57 South Korea RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 58 Latin America RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 59 Brazil RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 60 Argentina RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 61 Middle East & Africa RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 62 South Africa RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 63 Saudi Arabia RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 64 UAE RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 65 Kuwait RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End Use, By Region, And Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

RNAi Technology Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

Chapter 5. RNAi Technology Market: Application Business Analysis

Chapter 6. RNAi Technology Market: End Use Business Analysis

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, & End Use

Chapter 8. Competitive Landscape

List of Tables

List of Figures